New insulin candidate IBI3035 put to the test in healthy volunteers
NCT ID NCT07591519
First seen May 24, 2026 · Last updated May 24, 2026
Summary
This early-stage study checks if a new insulin formula called IBI3035 works similarly to an approved insulin (Awiqli) in healthy men. About 144 participants will receive a single dose of each formula and have their blood sugar and drug levels measured. The goal is to see if the two formulas are bioequivalent, not to treat any disease.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY PERSON are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Bishan Hospital of Chongqing
Chongqing, Chongqing Municipality, 402760, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.